You are here: Industry Insights > booster

News List

Moderna Begins Testing Booster Shot Aimed at Omicron drugs.com
January 27, 2022
Moderna Inc. announced Wednesday that it has launched a trial that will study the power of a redesigned booster shot
Booster Shots More Effective During Omicron Emergence Period drugs.com
January 26, 2022
Booster doses seem effective for the severe acute respiratory syndrome coronavirus 2 omicron variant..
Three New Studies Confirm Power of Booster Shots Against Omicron drugs.com
January 21, 2022
Booster shots are keeping the Omicron variant from landing millions of Americans in hospitals, emergency...
Another Study Finds Vaccine Booster 'Neutralizes' Omicron drugs.com
January 20, 2022
If you need more proof that a third shot of COVID vaccine is needed, new British research confirms that boosters can "neutralize" the virus' Omicron variant.
Moderna eyes combined Covid-19, flu booster by 2023 Pharmaceutical-Technology
January 19, 2022
Moderna CEO Stéphane Bancel also said an Omicron-specific Covid-19 vaccine will enter clinical development in a matter of weeks.
Pregnant women urged to receive COVID-19 booster amid surging cases pharmatimes
January 10, 2022
The UK government has warned that more than 96% of pregnant people admitted to hospital with COVID-19 symptoms were unvaccinated.
CDC advisory panel in favor of Pfizer vaccine booster for ages 12 to 15 FirstWordPharma
January 06, 2022
An advisory panel of the US Centers for Disease Control and Prevention (CDC) on Wednesday voted to recommend booster shots of Pfizer and BioNTech's COVID-19 vaccine be made available to 12- to 15-year-olds, as reported by Investing.com.
CDC Backs Boosters for High-Risk Children Ages 5 to 11 Years drugs
January 04, 2022
The U.S. Centers for Disease Control and Prevention on Tuesday backed the emergency use approval of the Pfizer COVID-19 booster shot for high-risk children between the ages of 5 and 11 years.
Valneva Announces Positive Booster Data for COVID Vax Candidate contractpharma
December 17, 2021
Valneva SE announced positive homologous booster data from the Phase 1/2 study, of its inactivated, adjuvanted COVID-19 Vaccine candidate, VLA2001.
COVID Booster Cuts Death Rate by 90%, Israeli Study Finds Drugs
December 09, 2021
Booster doses of Pfizer's coronavirus vaccine set recipients up to effectively withstand the ravages of both the Delta and Omicron variants, a group of new studies suggest.

Previous page 1 2 Next page